USD 30.98 billion
Report ID:
SQMIG35H2109 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
67
|Figures:
77
Downstream Processing Market size was valued at USD 35.69 Billion in 2023 and is poised to grow from USD 41.12 Billion in 2024 to USD 127.64 Billion by 2032, growing at a CAGR of 15.21% during the forecast period (2025-2032).
In downstream processing," biosynthetic products, primarily pharmaceuticals, are recovered and purified from natural sources such as fermentation broth, plant tissues, and animal tissues. Along with the safe treatment and disposal of garbage, it also involves recycling reusable parts. In the production of drugs like hormones, vaccines (like insulin and human growth hormone), antibodies (like infliximab and abciximab), and antibiotics, it is an essential step. For instance, Merck and Wuxi National High-tech Industrial Development Zone reached a collaboration agreement in April 2022. The scale of Merck's manufacturing plant in Wuxi, Jiangsu Province, China, will be increased in compliance with the terms of the agreement. The production of commercial enzymes, flavourings, and natural perfumes also depends on it. In downstream processing, a variety of procedures are used to treat the product, including cell separation, filtration, product recovery, extraction, and purification, as well as treatment utilising chemical, physical, and biological techniques. The creation of biological and pharmaceutical goods such as vaccines, recombinant proteins and enzymes, antibiotics, antibodies, hormones, diagnostic enzymes, industrial enzymes, and natural fragrance and flavour compounds results from downstream processing. Expanding bioprocessing capacity, greater single-use technology acceptance in bioprocessing, rising R&D spending in pharmaceutical companies, and rising biopharmaceutical market demand are the primary factors driving the global market demand for biopharmaceuticals. For instance, the biopharmaceuticals sector of the global market is consistently growing.
The Global Downstream Processing Market is poised for substantial growth due to several key factors. Firstly, the increasing demand for biopharmaceuticals and biotechnology products is a significant driver. As the biopharmaceutical industry continues to expand, downstream processing technologies play a pivotal role in the purification and production of biotherapeutic products, driving the demand for downstream processing solutions.
However, Despite the promising growth prospects, the Global Downstream Processing Market faces challenges that could hinder its expansion. One such challenge is the high cost associated with downstream processing equipment and consumables. The initial capital investment required for setting up downstream processing facilities can be prohibitive for smaller biotech companies and startups, potentially limiting market growth.
Nevertheless, advancements in chromatography and filtration techniques are enhancing the efficiency and scalability of downstream processing, making it more cost-effective. Moreover, the growing trend towards single-use and disposable technologies in biomanufacturing is simplifying downstream processes, reducing the risk of cross-contamination, and accelerating production, further propelling market growth.
Global Market Size
USD 30.98 billion
Largest Segment
Antibiotic Production
Fastest Growth
Antibiotic Production
Growth Rate
15.21% CAGR
To get more reports on the above market click here to Buy The Report
The global downstream processing market is segmented on the basis of Product, Technique, Application, End user and region. By Product, the market is segmented into Chromatography columns and resins, filters, membrane adsorbers, single use products, other products. By Technique, market is segmented into Purification techniques, solid liquid separation, clarification/concentration. By Application, the market is segmented into Monoclonal antibody production, vaccines production, insulin production, immunoglobulin production, erythropoietin production, other applications. By End user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Technique
In 2022, the downstream processing market was dominated by the purification by chromatography segment, which contributed 40.98% of total revenue. Because single-use chromatography and filtration systems are the industry benchmarks for downstream bioprocessing, businesses are pursuing business development techniques including acquisition, merger, and agreement to diversify their chromatography offerings. Repligen, for instance, purchased BioFlex Solutions, a company situated in Newton, New Jersey. Aside from streamlining its supply chain, the acquisition expands and improves Repligen's line of single-use fluid management products. By adding more integrated components and assemblies, the incorporation of BioFlex Solutions increases its system offering.
The sector with the highest CAGR from 2023 to 2030 is solid-liquid separation, at 16.03%. Solid-liquid separation has various benefits, including the fact that it is easy to use, economical, and suitable for continuous manufacturing. The common challenge with this approach is strong shear forces created. In order to address these issues, recent innovations including depth filters, multistage depth filtration, alternating tangential flow microfiltration, and tangential flow filtration technologies are being used more frequently in high cell density processes.
Analysis by Product
The downstream processing market was headed by the chromatography systems category in 2022, which also had the biggest revenue share (41.29%). Ongoing R&D to improve the efficiency and speed of chromatography systems is anticipated to boost the segment's expansion. Thermo Fisher Scientific introduced the HyPeak chromatography system, their sole single-use chromatography system for bioprocessing, which plays a vital role in the production of therapeutic proteins and vaccines. Growth of the industry is also aided by an increase in deals and innovations involving chromatography systems.
The fastest CAGR, 16.10%, is anticipated for the filters segment between 2023 and 2030. The key factor propelling this market for downstream processing is the expansion of filters' viral inactivation utility. The effectiveness of BioEX hollow fiber and Planova 20N virus filters for the elimination of viral-size particles was examined by a team of researchers from Pennsylvania State University. It is hoped that such studies will accelerate the use of filters for biologics' downstream processing.
To get detailed analysis on other segments, Request For Free Sample Report
Due to government assistance for developing bioprocess technologies, rising medical costs, and an established healthcare infrastructure, North America held a lion's share of the downstream processing market in 2022 with a revenue share of 34.57%. Growth in the USA market is due to rising production and consumption of biopharmaceutic also, government support, the surge in chronic and infectious diseases. The manufacturers focuses on expanding their manufacturing facility and product portfolio and found new avenues for research. Additionally, major firms in the downstream processing market are growing their presence in this area.
Due to increasing investments in biotechnology by consumers and developers, the downstream processing market in the Asia Pacific is anticipated to increase at the fastest pace among all markets, 15.67%, between 2023 and 2030. Players are eager to deploy rapid analytical approaches to enable in-process planning and bioprocessing for improved medical facilities that are required by a big population base. Due to the expanding biopharmaceutical industry and rising demand for drugs and vaccines, China had the lion's share of the market share in the Asia Pacific region. Among China's most dynamic economic sectors, the biopharmaceutical sector is characterized by a constant revolution driven by cutting-edge biopharmaceutical technology and procedures.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Downstream Processing Market Drivers
Increasing Demand for Biopharmaceuticals to Bring Lucrative Opportunities
Advancements in Biotechnology
Restraints
Product-Specific Challenges
Costing in downstream process
Complexity and limitations
Request Free Customization of this report to help us to meet your business objectives.
These companies compete based on factors such as product portfolio, technological advancements, pricing strategies, customer relationships, and global presence. They strive to differentiate themselves by offering innovative solutions, providing excellent customer support, and continuously improving their offerings to meet the evolving demands of the biopharmaceutical industry.
Downstream Processing Market Top Player’s Company Profiles
Downstream Processing Market Recent Developments
In March 2024, MilliporeSigma announced a strategic partnership with Lotte to equip a former Bristol Myers Squibb (BMS) plant.
In March 2024, MilliporeSigma made a substantial advancement in enhancing manufacturing flexibility and productivity by introducing the EX-CELL® Advanced™ HD Perfusion Medium. This creative off-the-shelf cell culture media is designed to support perfusion processes, enabling high productivity even at low perfusion rates. This enhancement aims to boost production yield and accelerate the speed of clinical development.
In February 2024, BASF SE, based in Ludwigshafen, Germany, officially commenced the divestment process for its shares in two joint venture companies: BASF Markor Chemical Manufacturing (Xinjiang) Co, Ltd and Markor Meiou Chemical (Xinjiang) Co, Ltd, located in Korla, China. This decision formulated in late 2023 is by BASF's worldwide methodology regarding 1,4-butanediol (BDO), a key chemical in its portfolio.
Chromatography brought up in pharmaceutical industry with growing success in the textile industry, assisting with operations including material preparation and molecular characterization. The downstream processing chromatography industry has come up with advancements with some new therapeutic modalities including monoclonal antibody (mAbs)-based therapeutics.
Continuous processing is being used by pharmaceutical and biopharmaceutical companies, and regulatory agencies encourage real-time monitoring using process analytical technology (PAT) to manage the downstream process. A further factor influencing the expansion of chromatography systems will be the shift from bigger single-product facilities to smaller multiproduct facilities.
Manufacturers of biopharmaceuticals place a great deal of emphasis on efficient process control in automation. The highest level of intelligence-in-manufacturing is constantly evolving through distributed and centralised hardware/software automation systems, which are being addressed by industry-focused R&D activities.
Furthermore, the idea of a digital twin to facilitate control is demonstrated for a small-scale, end-to-end platform for producing monoclonal antibodies. In the manufacturing industry, automation would present a number of options to get around several obstacles to successful commercial operations.
Large-scale production must be taken into account by biotherapeutics developers from the outset of process development .
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analyses, the market is highly competitive, with key players focused on innovation, expanding their product portfolios, and enhancing customer support. As the biopharmaceutical industry continues to evolve, the downstream processing market is expected to play a vital role in enabling the production of high-quality and safe biopharmaceutical products. The downstream processing market has been experiencing steady growth in recent years. Factors such as the increasing demand for biopharmaceuticals, advancements in biotechnology, and the need for high-quality and purified products drive market growth. The market size is expected to expand further as the biopharmaceutical industry continues to grow and new therapies, including advanced cell and gene therapies, gain traction.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 30.98 Billion |
Market size value in 2031 | USD 110.79 Billion |
Growth Rate | 15.21% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Downstream Processing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Downstream Processing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Downstream Processing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Downstream Processing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2109
sales@skyquestt.com
USA +1 351-333-4748